Dr. Namandjé N. Bumpus joined F-Prime in 2025, where she serves as a strategic advisor on regulatory science, regulatory affairs, and policy, bringing deep expertise from her previous roles as FDA Principal Deputy Commissioner and Chief Scientist. Before the FDA, Dr. Bumpus was the E.K. Marshall and Thomas H. Maren Professor and director of the Department of Pharmacology and Molecular Sciences at the Johns Hopkins University School of Medicine, where her research advanced understanding of drug metabolism, mechanisms of drug-induced toxicity, pharmacogenetics, bioanalytical chemistry, infectious disease pharmacology, and single cell biology. She completed her postdoctoral fellowship at The Scripps Research Institute and holds a PhD in pharmacology from the University of Michigan and a bachelor’s degree in biology from Occidental College.
Dr. Bumpus is a past-president of the American Society for Pharmacology and Experimental Therapeutics, a fellow of the American Association for the Advancement of Science, and a member of the National Academy of Medicine.
Claire Knowlton joined F-Prime in 2025 as a Marketing Associate. Claire supports marketing initiatives through event planning and internal communications. Previously, she worked at an estate planning law firm, focusing on email and social media marketing.
Claire holds a BA in Marketing from Loyola University Chicago.
Abby Wagner joined F-Prime in September 2024, and currently holds a Senior Accountant role. She previously held an Assurance Senior position at Ernst & Young, LLP serving primarily private clients in the wealth and asset management industry.
Abby earned an MBA and BS in Accounting with a Minor in Finance from Auburn University.
Rosanne Yang is Senior Legal Counsel at Fidelity Investments and supports the F-Prime team on legal aspects of the firm’s operations, including portfolio company investments and exits, fund formation, ongoing fund administration, and day-to-day management company operations.
Rosanne joined Fidelity in 2024 from Goodwin Procter, where she was a Senior Associate in the firm’s Technology and Life Sciences groups. Rosanne has many years of legal experience counseling venture capital and private equity firms, public and private companies, and entrepreneurs on a variety of legal matters. While working at Goodwin Procter, she also served as a Legal Secondee for Bain Capital Life Sciences, offering insights on a broad spectrum of legal and compliance issues. Over the course of her legal career, Rosanne has worked across a broad spectrum of industries, including biotechnology, health care, medical devices, pharmaceuticals, software, information technology and financial services.
Rosanne received her J.D. from Columbia Law School, where she was a James Kent Scholar and an editor of the Columbia Journal of European Law. She received her LL.B from Peking University in International Studies, and her Master’s degree in International Affairs from Sciences Po Paris.
Rosanne is admitted to the Massachusetts and the New York bars.
Lisa Robidoux joined F-Prime as Senior Accountant in September 2024. Prior to joining F-Prime, she worked at RSM US LLP for two years, most recently as a Senior Associate in their Assurance practice, where she primarily focused on private clients in the technology and life science industries.
Lisa holds a B.S. in Business Administration with dual concentrations in Accounting and Management from the University of New Hampshire.
Karen joined F-Prime as Director of Human Resources where she is responsible for developing best practices and executing HR strategies that align with F-Prime’s goals. Her role centers on refining the firm’s HR function to deliver top-notch support to F-Prime employees as well as our portfolio companies. Her focus is to attract and retaining top talent, ensuring competitive and equitable compensation, and fostering a culture of continuous learning and professional development.
Prior to F-Prime, Karen served as an HR Business Partner at GMO LLC, where she provided strategic guidance on employee engagement, talent management and workforce planning to the Finance, Investment Product Strategy and Operations teams.
Steve Johnson is a Venture Partner with F-Prime based in Cambridge. He specializes in technology start-ups, investing, mentoring, and managing ambitious technology companies. Steve is committed to purpose-driven organizations, prioritizing customers, disruptive technologies, and impactful contributions to industries and markets. Steve’s background includes leading strategy, M&A, B2B and B2C2B, enterprise software organizations, scaling hyper-growth enterprise companies globally, helping raise over $2B in funding, and participating in the creation of billions in market value for these companies.
Previously, Steve served as the President and COO at Berkshire Grey (BG) the leader in AI and robotics for the supply chain industry. He helped launch the commercial business for them, growing from a couple of customers to tens of customers around the world during his 4.2 year tenure. While there, BG raised a series B, went public in 2021 and was acquired by SoftBank in July 2023 and is now a wholly owned subsidiary of SoftBank. Before Berkshire Grey Steve was the Chief Commercial Officer of Intelex, a global enterprise software company. Intelex was acquired for $570M in June 2019 by Industrial Scientific.
Prior to joining Intelex, Steve served as President and COO for Vidyard, and CRO for Hootsuite, an enterprise software company now used by over 80% of the Fortune 100 companies. At Hootsuite he managed the growth of the company from 27 people to over 1,000 people around the world.
Earlier in his career, Steve worked for a number of category creating software companies such as CRM, Relational Database management, Total Interaction Management, and other areas. Steve holds an MBA from Northwestern’s Kellogg Business School with an emphasis in management, marketing, and international business and a B.S. in accounting from Union College.
Jack Neureuter is a Senior Associate at F-Prime focused on early-stage crypto investments. Prior to joining F-Prime, Jack was an investor at Avon Ventures and a research analyst for Fidelity Digital Assets. Jack’s time as a crypto-focused research analyst has served as a foundation to better understanding the evolving digital asset landscape.
Jack holds a degree in Finance from UMass Amherst. His interest in the crypto space was sparked in 2017 with his initial encounter with Bitcoin.
Bala Varadhan is a Principal at F-Prime focused on early-stage crypto, blockchain, and Web3 investments. Before joining F-Prime, Bala was with Avon Ventures and previously honed his expertise at the Boston Consulting Group (BCG), where he specialized in private equity due diligence and growth strategy. Bala’s career also includes roles in private equity and law, which have equipped him with a strong foundation in investment and transactional analysis.
Bala holds an MBA from the Kellogg School of Management, a JD from the Pritzker School of Law, and dual B.A.s in Economics and Liberal Arts from The University of Texas at Austin. His interest in the crypto space began in 2013 with his initial exposure to Bitcoin.
Sachin Patodia is a Partner at F-Prime. Prior to joining F-Prime, Sachin founded Avon Ventures and accumulated nearly two decades of experience at Fidelity’s Asset Management group as a portfolio manager on the equities team. Sachin’s investment expertise began during his early years in product management at various tech startups, providing him with a background in both finance and technology.
Sachin earned an MBA from the Wharton School of Business and holds dual degrees from the University of Pennsylvania, a B.S.E. in Computer Science, and a B.S. in Economics. His passion for emerging technologies sparked his early involvement with Bitcoin in 2014.